Crinetics Pharmaceuticals, Inc. Interest Expense
Crinetics Pharmaceuticals, Inc. (CRNX) reported Interest Expense of $8.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-13.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2019-03-13
- Crinetics Pharmaceuticals, Inc. interest expense for the quarter ending 2017-12-31 was $1.00K.
- Crinetics Pharmaceuticals, Inc. interest expense for the quarter ending 2017-09-30 was $2.00K.
- Crinetics Pharmaceuticals, Inc. interest expense for the quarter ending 2017-06-30 was $3.00K.
- Crinetics Pharmaceuticals, Inc. interest expense for fiscal 2017 was $8.00K, a 27.27% decline from fiscal 2016.
- Crinetics Pharmaceuticals, Inc. interest expense for fiscal 2016 was $11.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $3.00K derived: sum of 2 quarters · filed 2019-03-13 | $6.00K derived: sum of 3 quarters · filed 2019-03-13 | $8.00K 10-K · filed 2019-03-13 |
| 2017-09-30 | $2.00K 10-Q · filed 2018-11-13 | $5.00K derived: sum of 2 quarters · filed 2018-11-13 | $7.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $3.00K 10-Q · filed 2018-08-30 | $5.00K 10-Q · filed 2018-08-30 | ||
| 2016-12-31 | $11.00K 10-K · filed 2019-03-13 |